MUR
36
-2
GT
21
-2
MHK
42
2
WU
16
2
TGNA
39
4
T
59
2
XYL
49
2
DTE
56
2
VMC
48
-2
VRTX
43
6
TMO
40
2
PSX
42
3
AON
49
2
L
41
4
NWSA
75
2
PX
40
-5
ZTS
19
3
DE
56
-2
IVZ
42
2
ADM
42
-2
MUR
36
-2
GT
21
-2
MHK
42
2
WU
16
2
TGNA
39
4
T
59
2
XYL
49
2
DTE
56
2
VMC
48
-2
VRTX
43
6
TMO
40
2
PSX
42
3
AON
49
2
L
41
4
NWSA
75
2
PX
40
-5
ZTS
19
3
DE
56
-2
IVZ
42
2
ADM
42
-2
Financhill
Back

PTC Therapeutics Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
43

PTCT
PTC Therapeutics

Last Price:
$50.18
Seasonality Move:
15.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

PTC Therapeutics Stock Forecast

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 34.6% based on the past 11 years of stock performance.
  • PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
  • Is PTC Therapeutics Stock Undervalued?
    The current PTC Therapeutics [PTCT] share price is $50.20. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 34.6% based on the past 11 years of stock performance.

PTC Therapeutics Stock Rating

Sell
43
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics overpriced?

  • PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

  • The current trend is moderately bullish and PTCT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com

52-Week Data

52-Week High:
58.38
52-Week Low:
28.72

Prediction Charts

Market Cap:
4B
Price in USD:
50.20
Volume:
3.4M
Beta:
0.82

Technical Analysis

SMA50:
47.59
SMA100:
49.15
SMA200:
45.19
52-Wk Change:
50.8%

Stock Predictions

  • Is PTC Therapeutics stock public?
    Yes, PTC Therapeutics is a publicly traded company.
  • What is the PTC Therapeutics stock quote today?
    The PTC Therapeutics stock price is 50.20 USD today.
  • How to buy PTC Therapeutics stock online?
    You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-2 49.01 48.83 49.66 48.12
Jun-3 48.86 50.69 51.38 48.29
Jun-4 51.23 51.13 51.57 50.43
Jun-5 50.84 51.73 51.98 50.52
Jun-6 52.24 52.13 52.98 51.56
Jun-9 52.90 51.69 52.93 51.39
Jun-10 51.69 51.74 52.33 51.42
Jun-11 51.93 50.82 52.07 50.75
Jun-12 50.84 50.98 51.40 50.33
Jun-13 49.47 51.26 51.50 49.47
Jun-16 51.04 51.87 51.95 49.86
Jun-17 52.24 50.85 52.45 50.64
Jun-18 50.88 50.43 51.29 50.21
Jun-20 50.16 50.20 51.21 49.64

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.73 per share, an increase this year of $11.47 per share, and a decrease next year of $7.92 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.